Similar articles

• Angiotensin-converting enzyme (kinase II) in pituitary gland of spontaneously hypertensive rats.

  Chevillard C, Saavedra JM. Chevillard C, et al. Regul Pept. 1983 Mar;5(4):333-41. doi: 10.1016/0167-0115(83)90291-4. Regul Pept. 1983. PMID: 6304820
• Increase in cyclic AMP levels and vasopressin release in response to angiotensin I in neurohypophyses: blockade following inhibition of the converting enzyme.

  Sirois P, Gagnon DJ. Sirois P, et al. J Neurochem. 1975 Nov;25(5):727-9. doi: 10.1111/j.1471-4159.1975.tb04398.x. J Neurochem. 1975. PMID: 172607 No abstract available.
• Demonstration and characterization of angiotensin-converting enzyme in human pituitary tissue.

  Tani M, Mizuno K, Hashimoto S, Kunii N, Niimura S, Yabe R, Watari H, Fukuchi S. Tani M, et al. Life Sci. 1986 Jun 23;38(25):2277-84. doi: 10.1016/0024-3205(86)90633-8. Life Sci. 1986. PMID: 3014244
• [Angiotensin I converting enzyme--properties, functions and methods of analysis].

  Siems WE, Halle W. Siems WE, et al. Pharmazie. 1982 Aug;37(8):539-44. Pharmazie. 1982. PMID: 6292961 Review. German. No abstract available.
• Pharmacology of angiotensin converting enzyme inhibitors. A review.

  Nelson EB, Pool JL, Taylor AA. Nelson EB, et al. Am J Med. 1986 Oct 31;81(4C):13-8. doi: 10.1016/0002-9343(86)90939-3. Am J Med. 1986. PMID: 3022580 Review.